• SENSEX
    NIFTY 50
Market

Tuesday's top brokerage calls: Kotak Bank, SBI Life and more

Updated : 2020-10-27 09:04:09

Among brokerages, CLSA maintains an 'outperform' rating on Kotak Bank after its September quarter earnings and has raised its target to Rs 1,600 per share from Rs 1,400. Meanwhile, it also upgraded SBI Life to 'buy' from 'outperform' with a target at Rs 1,000 per share. Here are the top brokerage calls for the day:

 CLSA on Kotak Bank:  The brokerage maintains an 'outperform' rating on the stock and has raised its target to Rs 1,600 per share from Rs 1,400 earlier. It added that collections in many segments are approaching pre-COVID levels.
CLSA on Kotak Bank: The brokerage maintains an 'outperform' rating on the stock and has raised its target to Rs 1,600 per share from Rs 1,400 earlier. It added that collections in many segments are approaching pre-COVID levels.
 Jefferies on Kotak Bank:  The brokerage maintains a 'buy' call on the stock with a target at Rs 1,700 per share. It added that comfort on asset quality will reflect in confidence to grow loans.
Jefferies on Kotak Bank: The brokerage maintains a 'buy' call on the stock with a target at Rs 1,700 per share. It added that comfort on asset quality will reflect in confidence to grow loans.
 Nomura on Kotak Bank:  The brokerage maintains a 'neutral' call on the stock with a target at Rs 1,570 per share. It said that valuations are rich at current levels.
Nomura on Kotak Bank: The brokerage maintains a 'neutral' call on the stock with a target at Rs 1,570 per share. It said that valuations are rich at current levels.
 CLSA on SBI Life : The brokerage upgraded the stock to 'buy' from 'outperform' with a target at Rs 1,000 per share. It added that valuations are reasonable at current levels.
CLSA on SBI Life: The brokerage upgraded the stock to 'buy' from 'outperform' with a target at Rs 1,000 per share. It added that valuations are reasonable at current levels.
 Jefferies on SBI Life:  The brokerage maintains a 'buy' call on the stock with a target at Rs 1,040 per share. It added that it is optimistic about the company's ability to cross-sell to SBI's clients.
Jefferies on SBI Life: The brokerage maintains a 'buy' call on the stock with a target at Rs 1,040 per share. It added that it is optimistic about the company's ability to cross-sell to SBI's clients.
 CLSA on NTPC:  The brokerage maintains a 'buy' call on the stock with a target at Rs 140 per share. It noted that the time for buyback for the firm is now.
CLSA on NTPC: The brokerage maintains a 'buy' call on the stock with a target at Rs 140 per share. It noted that the time for buyback for the firm is now.
 CLSA on Torrent Pharma:  The brokerage maintains a 'buy' call on the stock with a target at Rs 3,450 per share. It further stated that the portfolio mix augurs well for healthy earnings growth.
CLSA on Torrent Pharma: The brokerage maintains a 'buy' call on the stock with a target at Rs 3,450 per share. It further stated that the portfolio mix augurs well for healthy earnings growth.
 Jefferies on Torrent Pharma : The brokerage retains an 'underperform' call on the stock and cut its target to Rs 2,322 from Rs 2,397 earlier. Revenue growth challenges will persist in the near term, it added.
Jefferies on Torrent Pharma: The brokerage retains an 'underperform' call on the stock and cut its target to Rs 2,322 from Rs 2,397 earlier. Revenue growth challenges will persist in the near term, it added.
Live TV

recommended for you

Ask Our Experts CNBC TV18

Advertisement